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Biotechnologies being developed for use in animal agriculture include the commonly practiced technologies of artificial insemination and embryo 
transfer, as well as the developing technologies associated with in vitro produc-
tion of embryos, the splitting and cloning of embryos, marker-assisted selection 
including sexing of the embryo, and the transfer of new genes into an embryo. 
Each technology should be considered separately when assessing the benefits and 
risks of each to animals and humans because each is distinctly different and only 
one, gene transfer, involves recombinant DNA technology.
Genetic improvement of farm animals by traditional parent selection has 
been slow, especially for traits of low heritability. Nevertheless, the rate of in-
crease in milk production has been greatly accelerated by artificial insemination 
of cows with semen from highly-selected, performance-tested bulls. In a limited 
way, the valuable genetics of a few very high production cows has been extended 
several-fold by the use of superovulation and embryo transfer. Conventional 
mating, artificial insemination and embryo transfer all have the disadvantage of 
propagating undesirable genes of a high-performance male or female along with 
the selected genes. Exciting new developments in animal biotechnology offer 
hope for modeling and designing animals to fit market and environmental needs 
and for rapidly propagating or identifying the animals of superior performance. 
This review will focus on each of these biotechnologies, their development status, 
use or potential use in animal agriculture, benefits and risks to the consumer of 
animal products and risks to animals.
A R T I F I C I A L  I N S E M I N A T I O N
Use of artificial insemination developed rapidly in dairy cattle beginning in 
the late 1940s and 1950s when it was realized that bull sperm could be stored 
frozen and that 2-4 ejaculates per week from a bull could provide sufficient 
sperm after frozen storage to inseminate at least 2,000 cows. This allowed ex-
treme selection of the sires, resulting in a more than two-fold increase in ge-
netic ability for milk production of dairy cows. At present the pregnancy
rates are 60-65 percent and most dairy cows are mated by artificial insemina-
tion (70 percent U.S., greater than 90 percent Europe). While this technology 
has been developed for use in other domestic animals, the cost-benefit ratio 
has been favorable in the U.S. only for wide-scale use in dairy cattle or use by 
breeders at the top of the breeding stock pyramid for beef cattle, sheep and 
swine. It is a common practice in poultry breeding. The benefit to consumers 
has been low cost and availability of dairy products of high quality. The risks 
to the animals are essentially none. While it is sometimes argued that high 
milk production could reduce cow longevity, older cows declining in milk 
production are usually slaughtered for meat before becoming aged. For re-
view of artificial insemination see Hafez, 1987.
EMBRYO TRANSFER
Embryo transfer (Figure 1) is being used primarily in dairy cattle and the top 
seedstock herds of beef cattle. It has the advantage of genetic improvement 
through both sire and dam rather than the sire alone, as with artificial in -
semination. There are approximately 250,000 calves born annually in the 
U.S. from embryo transfer. Its use has been limited because the technology of 
superovulation and embryo transfer has allowed only 20-30 calves per year 
from a cow and because it is more expensive than artificial insemination.
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g e n e tic a lly  s u p e r io r  co w  th a t  h a d  b een  in s e m in a te d  w i th  sp e r m  f r o m  a  b u l l  o f  h ig h  g e n e t ic  v a lu e . 
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e s tro u s  cyc le  w i th  th e  d o nor. T h e  e m b ry o s  c a n  b e  s to re d  f r o z e n  o r  sexed . E ach  c a l f  b o r n  is n o  m o re  
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low, o n ly  a  f e w  reach  th e  le v e l o fp r o d u c t io n  o f  th e  p a r e n ts .
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One commercial use for ‘in vitro’ production of embryos is illustrated above (Schaefer el al., un-
published). This breeding plan is used to eliminate maintenance of a beef brood cow. Other uses 
when oocytes are recovered by transvaginal laparoscopy from valuable cows include the produc-
tion of large numbers of offspring from a valuable cow, or old or incapacitated cows.
Embryos can, and are, being frozen, and in a few cases sexed or split to 
double the number of embryos. Procedures for superovulation and embryo 
transfer are nonsurgical and present little risk to the cow donating the em-
bryo or the recipient receiving it and cows can be successfully superovulated 
or bred at the second estrus cycle after superovulation. The animal risk is low 
and the benefit to consumers is manifest as more abundant, lower cost, 
higher quality milk and meat products. For review of embryo transfer see 
First, 1991; Seidel, 1991; and Wilmut et al., 1992. Artificial insemination and 
especially embryo transfer are the delivery mechanisms by which the new re-
productive and genetic biotechnologies now under development will be de-
livered to animals for propagation.
IN VITRO P R O D U C T I O N  O F  E M B R Y O S
In vitro production of embryos depends on efficient systems for culture of 
oocytes and sperm, fertilization and embryo culture. This technology is be-
ing developed for all food-producing animals and is presently best developed 
for cattle where it is beginning to be applied. Parts of this technology are es-
sential for cloning of embryos and for gene transfer. Several breeding compa-
nies are applying this technology commercially. Its application has been in 
two forms. In field trials in the U.S., Japan and Great Britain, embryos are 
produced in vitro from abattoir-recovered oocytes of selected breeds that are 
fertilized with semen of highly selected bulls. This is done with the objective
Biotechnologies
to replace the brood cow in beef production with in vitro produced embryos 
(Schaefer et al., unpublished) as shown in Figure 2. Each group has used this 
approach for a different genetic purpose. The application in Japan is to use, 
for both reproduction and valuable beef, the young Wagyu females that pro-
duce expensive Kobi beef. In Britain, the use is to produce valuable beef from 
dairy cows; while the use in the U.S. is to produce both embryo transfer re-
cipient females and beef from young females derived from in vitro produc-
tion of embryos, as shown in Figure 2 (Schaefer et al., unpublished). Cattle 
oocytes can also be recovered from follicles matured in vivo by recovery using 
ultrasound-guided vaginal laparoscopy. Recovery of these oocytes from ge-
netically valuable cows provides a supply of oocytes of high genetic value for 
use in gene transfer and production of oocytes and embryos for cloning. Re-
cent estimates indicate that one genetically valuable cow could produce 10 
oocytes every 2-3 days throughout the year (Krimpenfort et al., 1991; Van 
der Schans et al., 1991) or approximately 100 calves per year, a big increase 
from that achieved by superovulation. Several embryo transfer companies 
are preparing to offer this in vitro embryo production service. The major 
challenge to researchers is to harvest and mature the thousands of growing 
oocytes and small follicles of domestic species. This would further increase 
the pool of oocytes available from genetically valuable animals. Application 
of this technique to fetal ovaries would allow rapid genetic progress through 
marker-assisted selection and velogenesis (Georges, 1991). The second part 
of producing embryos in vitro is the sperm capacitation and fertilization sys-
tem. In general, any agent that causes Ca+* entry into the sperm acrosome 
and a pH increase within the sperm causes capacitation. Numerous capacita-
tion systems have been developed including high ionic strength media, gly- 
cosaminoglycans (such as heparin), aging, pH shift, calcium ionophores, caf-
feine and oviduct fluid. With appropriate sperm capacitation and incubation 
in serum-free medium at body temperature, in vitro fertilization rates have 
been reported as high as 70-80 percent in cattle, sheep, swine and goats 
(Parrish, 1990; First, 1991). Embryos of domestic animals can be successfully 
cultured in surrogate oocytes of rabbits and sheep or cultured with oviduct 
cells or oviduct cell conditioned media and recently successfully cultured in a 
defined media (Rosenkrans and First, 1990; First, 1991). While investigators 
are still searching for uterine factors and growth factors that may further in-
crease the survival and development of cultured embryos, present methods 
are satisfactory for commercial use. The in vitro production of embryos as 
now practiced presents several benefits to society other than a lower-cost, 
more-abundant food product. This technology is economical to the environ-
ment and food supply as it eliminates beef brood cows. It permits use of ga-
metes, cells and embryos in research rather than use of animals. To the live-
stock producer it could allow cost-effective genetic improvement. The risks 
are minimal when oocytes are recovered transvaginally and none when they 
are recovered as an abattoir by-product. Pregnancy rates are approximately
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Donor embryos are obtained by flushing the uterus ofa genetically superior cow after superovu-
lation and insemination with sperm from a genetically superior bull. Each cell of each 30 to 60 
cell stage embryo is transferred into an enucleated oocyte. The embryos produced by this process 
can be used to supply donor cells to further increase the number of cloned embryos by recloning.
60 percent and offspring are normal (Monson et al., 1992). For a review of 
this technology, see Leibfried-Rutledge el al., 1989; Gordon and Lu, 1990; 
First, 1991; Flansel and Godke, 1992. These same methods for in vitro pro-
duction of embryos are also beginning to be used to propagate zoo animals 
and to save endangered species (Wildt et al., 1992).
C L O N I N G  O F  D O M E S T I C  A N I M A L S
Twins are presently being produced with good efficiency by bisection of em-
bryos and a few cells left on the bisection knife have been used to sex the bi-
sected embryos. The most promising method for production of large num-
bers of offspring is nuclear transplantation. This procedure has successfully 
produced viable embryos and offspring in cattle, sheep, rabbits and swine. 
The procedure (Figure 3) involves transfer of a blastomere or nucleus from 
the valuable embryo at a multicellular stage (usually 20-120 or more cells) 
into an enucleated metaphase II oocyte. The oocyte then develops to a multi-
cellular stage and is used as a donor in a serial recloning (First and Prather, 
1991; Stice, 1992). Nuclear transplantation is being developed in private in-
dustry as well as by university research. Thus far, nuclear transplantation in 
cattle has been successfully performed using low-cost, in vitro matured oocytes 
from abattoir-recovered ovaries and with serial nuclear transfers. However, 
the efficiency is less than desired with approximately 20-25 percent of the 
nuclear transplantations resulting in transferable embryos and approximately
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30 percent of the embryos transferred into the cows resulting in completed 
pregnancies. Throughout the U.S. and Canada, several hundred pregnancies 
have been produced in cattle by this procedure and recloning has been per-
formed. To date, the largest number of calves cloned from one embryo has 
been 11 calves born at Granada Genetics in 1990 (First and Prather, 1991). 
The keys to a successful cloning system for a livestock industry are the ability 
to use donor embryos of larger cell numbers to produce many offspring and 
the capacity to use cells from cloned embryos as the donor nuclei for another 
generation of clones. In sheep embryos, the frequency of development to 
blastocysts after use of donor cells from the blastocyst inner cell mass was 57 
percent and pregnancies resulted. In rabbits, blastocysts have been produced 
from inner cell mass cells but at a lower frequency than from the 32-cell 
morula stage blastomeres. In cattle, embryos at the stages of morula or the 
inner cell mass of blastocysts have produced good results as donors in clon-
ing. This is approximately the stage where embryonic stem cells can be recov-
ered and multiplied in culture in a mouse. If similar stem cell isolation and 
multiplication were done in domestic animals and if stem cells should prove 
useful in cloning by nuclear transplantation, the number of possible clones is 
unlimited (First, 1991). When developed to high efficiency, cloning provides 
a nearly phenotypic selection and propagation system for replicating valu-
able animals. For example, traits with heritabilities of approximately 30 per-
cent are expected to increase to nearly 70 percent. It will also be used for 
rapid propagation of precious transgenic animals. The benefits of nuclear 
transfer include a nearly phenotypic selection, accelerated genetic improve-
ment or environmental adaptation and characterized and predictable pro-
duction performance, nutrient requirements, disease resistance and exten-
sive screening of clonal lines for genetic defects, disease resistance and envi-
ronmental adaptation before multiplication and release for use. The risks are 
low to none for the animals supplying donor embryo cells or the recipient 
oocytes, but the process at the present state of the art results in less than nor-
mal embryo survival before embryo transfer and less than normal pregnancy 
rates and calving rates. Also, some of the calves are born larger than normal 
and require assisted delivery. It is expected that with time and continued re-
search these problems will be understood and corrected. For reviews of clon-
ing of domestic animals, see First and Prather, 1991; Bondioli, 1992; Prather 
et al., 1992; and Seidel, 1992.
G E N E  T R A N S F E R
Successful production of transgenic food-producing animals requires the 
ability to efficiently achieve development of the transgenic embryo and ge-
nome integration of the transgene. Precise genetic modeling and appropriate 
promoter sequences to achieve expression at a high level in a tissue of choice 
and of the trait desired are necessary. Transgenic cattle, sheep, swine and rab-
bits have been made by microinjection of DNA into a pronucleus of a one-
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Microinjection of concentrated DNA (a gene) into a pronucleus of a bovine egg. Note the egg is 
first centrifuged to concentrate the cytoplasm against one side such that the pronuclei can be visualized 
in the cleared area.
cell zygote (Figure 4), transgenic fish by injection of DNA into oocytes and 
chickens by infection of genes into eggs (Hansel and Weir, 1990; First and 
Haseltine, 1991; Rexroad, 1992). Principle genes introduced into fish have 
been growth hormone genes resulting in production of fish that grow 2-3 
times faster than normal. Genes imparting cold resistance to warm water 
species have also been expressed by transgenic fish. Transgenic chickens have 
been made which express increased growth from a growth hormone 
transgene and increased viral resistance from interference with cell receptors 
for avian viruses. Cattle, sheep and swine have been made transgenic for 
various growth hormones without significant increases in growth, but with 
decreased fat in the carcass. Use of tissue-specific promoter sequences and 
appropriate promoter control of the level of gene expression should improve 
growth responses. The SKI oncogene is an example of a gene that enhances 
muscle growth in mice and swine. Other genes may be identified that in-
crease muscle tenderness. When appropriate disease resistance genes are 
identified, it should be possible to engineer high-producing animals for sur-
vival in high-disease environments. Genes for expanding the MHC complex 
and globins have been introduced into mice and sheep. Cells of animals have 
been genetically modified to resist the entire herpes family and defective vi-
ruses have been used in chickens to promote receptor resistance to patho-
genic viruses (Hansel and Weir, 1990; First and Haseltine, 1991; Rexroad, 
1992). The ability to target gene expression exclusively to the mammary 
gland will allow modification of milk composition to make novel cheeses, 
remove milk fat, lactose or allergenic proteins and increase protein content. 
Thus far, transgenic mice have been made which express new caseins or no 
milk fat. It is likely that some cows will be designed to produce milk for
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specialty dairy products while most cows may be engineered to produce little 
or no fat in their milk. It is also expected that pharmaceutical products will 
be produced from milk of cows expressing pharmaceutical transgenes in their 
mammary glands. Already transgenic mice, sheep, goats and pigs have been 
produced which expressed either the pharmaceutical proteins of tissue plas-
minogen activator clotting factor 9, alpha-l-antitrypsin, lactoferrin, euro- 
kynase, follicle-stimulating hormone, protein C, human growth hormone or 
interleukin 2 in their milk (First et al., 1991; Rexroad, 1992). Gene transfer 
usually results in one or two transgenic animals forming the beginning of a 
transgenic line. It, therefore, does not initially impact a large part of a popu-
lation and requires artificial insemination, or in vitro production of em-
bryos, or cloning or combinations of the above to produce animals or fish 
which are commercially useful. Gene transfer is most useful for introduction 
of genes not found in a population or deletion of genes not wanted, whereas 
marker-assisted selection is considered to be much more efficient in chang-
ing a population if the gene in question exists in the population. The benefits 
from gene transfer other than increasing the efficiency of animal production 
include the development of animals better fit for specific environments, in-
cluding disease resistance; the production of new animal products and higher 
quality products, for example more digestible milk; removal of allergenic 
compounds from milk; etc. The technique of gene transfer imposes no direct 
animal risk. However, a greater than normal early loss of embryos occurs.
The cost of gene transfer and use of animals can be considerably reduced 
by transfer of genes into in vitro produced embryos (First et al., 1991; 
Krimpenfort et al., 1991). Faulty modeling of the gene and promoter con-
struct can result in insertion of the transgene at an inappropriate site with 
disturbance of expression of another gene or expression in other than the tis-
sue or cell targeted in the modeling of the transgene, or expression at an in-
appropriate time in animal development. In the future, these risks will likely 
be reduced or eliminated by advances in several areas. These include the in-
troduction of DNA into cultured cells that can be sampled and screened for 
appropriate expression before use in nuclear transfer to make embryos for 
transfer into cows. The use of cultured cells to make animals also allows site 
specific gene transfer or deletion through homologous recombination, 
thereby eliminating inappropriate sites of integration. Improved modeling of 
the desired outcome of the transfer gene will occur as gene mapping projects 
provide genome knowledge sufficient to allow accurate modeling of the ge-
nome and the gene construct. Perhaps the greatest challenge will be the de-
velopment of consumer confidence that specific genetically engineered ani-
mals may not be at risk and that engineered products are safe whereas other 
transgenics may be rejected because animals are at risk. For review of gene 
transfer see Rexroad, 1992; First et al., 1991; First and Haseltine, 1991; 
Wilmut et al., 1990; and Hansel and Godke, 1992.
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M A R K E R - A S S I S T E D  S E L E C T I O N
Efforts to map the genomes of domestic animals and similarities with the 
mapped human genome have resulted in DNA markers that are beginning to 
be associated with desired or undesired productivity traits. For example, a 
restriction fragment linked polymorphism (RFLP) in at least one family of 
Holstein cattle has been associated with high milk production. Several artifi-
cial breeding companies now use this DNA marker to select for higher milk 
production. Markers for K-casein that relates to protein content of the milk 
and markers for selection against a neurological defect in Brown Swiss cattle 
are also in use (Georges, 1991). Rapid development of markers for use in 
phenotypic and genetic selection is expected as more of the genome and spe-
cific linkages to production traits are understood. Because the genomes of 
higher mammals are similar and gene mapping efforts across species are co-
ordinated, we are rapidly increasing our knowledge of the genome. The ap-
plied value of gene mapping and genetic markers is primarily through asso-
ciation of markers with productivity, disease resistance and product quality: 
traits of interest. But marker-assisted selection has several other advantages. 
Markers can be used to perform early genetic selection on gametes, embryos 
or newborn animals. Markers can be used for DNA fingerprinting and accu-
rate animal identification or association of product with animal, herd or pro-
cessing plant. Markers are used to screen for genetic defects and when genes 
are introduced from other populations, markers can be used to track their 
segregation in the population. Because marker-assisted selection imposes 
little to no risk to the animals donating blood, sperm, or embryos for assay 
and imposes no risk to the consumer, marker-assisted selection is expected 
in the short term to be the most commonly used of the above animal biotech-
nologies. For review of marker-assisted selection see Dentine, 1992; Georges, 
1991; Fries et al., 1989; and Massey and Georges, 1992. Several other biotech-
nologies impact animal agriculture, but also are expected to impose no risk 
to animal or consumer. These include the use of DNA fingerprinting for di-
agnosis of disease microorganisms, the development of new vaccines using 
recombinant technology and the use of engineered colostrums to protect ani-
mals and humans from disease.
S U M M A R Y
In summary, it is apparent that every biotechnology is different. Each gene 
construct is different and each must be examined for its individual benefits 
and risks. Some biotechnologies reduce the need for animals in research or 
reduce the numbers needed for food production. Some protect the health of 
the animal or make it more fit for a changed environment and some allow for 
the preservation and rapid repopulation of an endangered species. Most im-
portantly, biotechnology is a series of tools to be used intelligently or care-
lessly by humans as a choice of humans. We must choose wisely, but avoid
Biotechnologies
condemnation and rejection of the tool. Like fire, clothing and the wheel, we
may someday need it and be wise enough to use it.
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